EP Patent

EP2990032A1 — Use of glyceryl trinitrate for treating traumatic edema

Assigned to G Pohl Boskamp GmbH and Co KG · Expires 2016-03-02 · 10y expired

What this patent protects

Use of glyceryl trinitrate (GTN) for treating traumatic edemas.

USPTO Abstract

Use of glyceryl trinitrate (GTN) for treating traumatic edemas.

Drugs covered by this patent

Patent Metadata

Patent number
EP2990032A1
Jurisdiction
EP
Classification
Expires
2016-03-02
Drug substance claim
No
Drug product claim
No
Assignee
G Pohl Boskamp GmbH and Co KG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.